Create Free Account

By creating account you will get access to hot stocks & personalised emails

Crispr Therapeutics AG

Healthcare US CRSP

47.67USD
-1.01(2.07%)

Last update at 2024-12-11T18:57:00Z

Day Range

47.3549.38
LowHigh

52 Week Range

37.5591.10
LowHigh

Fundamentals

  • Previous Close 48.68
  • Market Cap4661.15M
  • Volume816020
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-279.01901M
  • Revenue TTM271.71M
  • Revenue Per Share TTM3.40
  • Gross Profit TTM -570.69700M
  • Diluted EPS TTM-2.7

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -650.50000M 379.53M -348.05600M 67.31M -164.42800M
Minority interest - - - - -
Net income -650.17500M 377.66M -348.86500M 66.86M -164.98100M
Selling general administrative 102.46M 102.80M 88.21M 63.49M 48.29M
Selling and marketing expenses - - - - -
Gross profit -109.81400M 913.08M 0.54M 289.59M 3.12M
Reconciled depreciation 24.17M 17.95M 9.18M 4.72M 3.52M
Ebit -697.33300M 355.57M -354.43500M 42.02M -162.46200M
Ebitda -673.16100M 373.53M -345.25100M 46.74M -158.94300M
Depreciation and amortization 24.17M 17.95M 9.18M 4.72M 3.52M
Non operating income net other 22.66M 6.00M 6.38M 20.57M -5.48500M
Operating income -673.16100M 373.53M -354.43500M 46.74M -158.94300M
Other operating expenses 673.60M 539.55M 354.98M 242.85M 162.07M
Interest expense -46.83300M 23.96M 6.38M 25.29M 0.00000M
Tax provision -0.32500M 1.87M 0.81M 0.45M 0.55M
Interest income - - - 5.47M 4.28M
Net interest income - - - - 0.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.32500M 1.87M 0.81M 0.45M 0.55M
Total revenue 0.44M 913.08M 0.54M 289.59M 3.12M
Total operating expenses 563.35M 539.55M 354.98M 242.85M 162.07M
Cost of revenue 110.25M - - 179.36M 113.77M
Total other income expense net 22.66M 6.00M 6.38M 20.57M -5.48500M
Discontinued operations - - - - -
Net income from continuing ops -650.17500M 377.66M -348.86500M 66.86M -164.98100M
Net income applicable to common shares -650.17500M 377.66M -348.86500M 66.86M -164.98100M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 2229.57M 2243.06M 2751.88M 1827.97M 1066.75M
Intangible assets 0.02M 0.07M 0.12M 0.18M 0.23M
Earning assets - - - - -
Other current assets 14.39M 37.71M 38.08M 26.14M 43.68M
Total liab 346.77M 367.58M 352.42M 163.73M 127.33M
Total stockholder equity 1882.80M 1875.48M 2399.46M 1664.23M 939.42M
Deferred long term liab - - - - -
Other current liab 50.91M 65.51M 91.90M 71.46M 41.71M
Common stock 2.50M 2.44M 2.39M 2.28M 1.85M
Capital stock 2.50M 2.44M 2.39M 2.28M 1.85M
Retained earnings -999.70000M -846.09000M -195.91500M -573.57600M -224.71100M
Other liab - 18.29M 19.66M 19.41M 26.17M
Good will - - - - -
Other assets - 16.27M 22.20M 18.14M 6.14M
Cash 389.48M 211.88M 923.03M 1168.62M 943.77M
Cash and equivalents - - - - -
Total current liabilities 108.79M 121.11M 119.88M 94.26M 57.11M
Current deferred revenue 4.11M 12.32M 1.01M 2.34M 0.96M
Net debt -150.84500M 32.14M -698.00100M -1107.19100M -891.23200M
Short term debt 15.62M 15.84M 12.16M 11.36M 8.49M
Short long term debt - - - - -